Ajinomoto

Enhanced Medical Nutrition specializes in the development of medical food products aimed at improving patient outcomes related to surgery. The company focuses on research, development, and distribution of evidence-based clinical nutrition specifically designed for the perioperative setting. Their products assist in rehabilitation, promote wound healing, and manage the protein needs of individuals who are ill and aging. By utilizing their innovative medical foods, Enhanced Medical Nutrition enables patients to reduce postoperative insulin resistance and enhance overall health during recovery periods.

Safire Technology Group specializes in the development of lithium-ion electrolyte additive technology aimed at enhancing battery safety. Their innovative technology prevents explosions and fires by facilitating an instantaneous transformation from liquid to solid upon mechanical impact, providing an additional layer of protection. This advancement not only enhances the safety of batteries but also imparts ballistic protection, making electric applications safer and more reliable. The company's solutions are designed to deliver cost-effective and higher-performing outcomes for clients in the electric applications sector.

TechMagic is a developer of innovative cooking robots aimed at automating culinary tasks in the food industry. By leveraging artificial intelligence, machine learning, and robotics, the company addresses labor costs and enhances productivity for restaurants. Its automatic cooking solution is designed to streamline kitchen operations, allowing businesses to reduce reliance on human labor while maintaining high efficiency. TechMagic's mission is to integrate advanced technologies into daily life, ultimately creating a richer lifestyle through the automation of routine tasks.

Forge Biologics, Inc. is a contract development and manufacturing organization (CDMO) specializing in gene therapies and genetic medicines. Founded in 2019 and based in Columbus, Ohio, the company focuses on developing and manufacturing therapeutics, particularly for viral vector gene therapies aimed at treating genetic diseases. Notably, it offers a novel approach combining adeno-associated virus (AAV) and umbilical cord transplant to address infantile Krabbe disease, a severe neurodegenerative disorder. Additionally, Forge Biologics collaborates with scientists, physicians, biotech and pharmaceutical companies, and patient groups to facilitate the progression of gene therapy programs from preclinical development through to clinical and commercial-scale manufacturing. The company is committed to enabling access to transformative medicines for patients suffering from rare genetic diseases.

Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.

SARAH Inc. is a Tokyo-based company established in 2014 that focuses on developing a mobile application designed for exploring and sharing restaurant menu images. This application allows users to discover culinary options by searching through menu-based posts and offers a platform for users to share recommendations and suggestions regarding various dishes. By listing restaurants that serve diverse cuisines, SARAH Inc. facilitates a unique dining experience, enabling users to select their dining destinations based on specific menu items and personal preferences.

Tsubame BHB Co., Ltd. is a Tokyo-based company that specializes in the research, development, and manufacturing of on-site ammonia production systems and catalysts. Founded in 2017, Tsubame focuses on commercializing ammonia synthesis through innovative electride catalyst technology, which allows for flexible production conditions. The company's systems are designed for small-scale plants, addressing critical environmental and food-related challenges while promoting a sustainable society. By enabling on-site ammonia production, Tsubame aims to reduce transportation and storage costs for its clients, contributing to more efficient resource management.

On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Granules OmniChem Private Limited is a pharmaceutical company that specializes in contract development and the manufacturing of active pharmaceutical ingredients (APIs). Established in 2011 and headquartered in Visakhapatnam, India, the company operates as a joint venture between Granules India Limited and S.A. Ajinomoto OmniChem N.V. Since May 2020, Granules OmniChem has functioned as a subsidiary of S.A. Ajinomoto OmniChem N.V., focusing on delivering high-quality services and products within the pharmaceutical sector.

Tsubame BHB Co., Ltd. is a Tokyo-based company that specializes in the research, development, and manufacturing of on-site ammonia production systems and catalysts. Founded in 2017, Tsubame focuses on commercializing ammonia synthesis through innovative electride catalyst technology, which allows for flexible production conditions. The company's systems are designed for small-scale plants, addressing critical environmental and food-related challenges while promoting a sustainable society. By enabling on-site ammonia production, Tsubame aims to reduce transportation and storage costs for its clients, contributing to more efficient resource management.

Tsubame BHB Co., Ltd. is a Tokyo-based company that specializes in the research, development, and manufacturing of on-site ammonia production systems and catalysts. Founded in 2017, Tsubame focuses on commercializing ammonia synthesis through innovative electride catalyst technology, which allows for flexible production conditions. The company's systems are designed for small-scale plants, addressing critical environmental and food-related challenges while promoting a sustainable society. By enabling on-site ammonia production, Tsubame aims to reduce transportation and storage costs for its clients, contributing to more efficient resource management.

Cambrooke Therapeutics develops and manufactures therapeutic nutrition products administered under medical supervision for patients needing specialized dietary therapies. Their products focus on natural intact protein designed for metabolic disorders, renal diseases, and phenylketonuria, supporting dietary management by providing targeted protein nutrition for individuals who cannot adequately metabolize certain amino acids. The company aims to improve treatment outcomes and the dietary experience for patients requiring clinically supervised diets.

Tsubame BHB Co., Ltd. is a Tokyo-based company that specializes in the research, development, and manufacturing of on-site ammonia production systems and catalysts. Founded in 2017, Tsubame focuses on commercializing ammonia synthesis through innovative electride catalyst technology, which allows for flexible production conditions. The company's systems are designed for small-scale plants, addressing critical environmental and food-related challenges while promoting a sustainable society. By enabling on-site ammonia production, Tsubame aims to reduce transportation and storage costs for its clients, contributing to more efficient resource management.

Hinoman is a pioneering company dedicated to addressing the increasing global demand for healthy, secure, and sustainable food. It specializes in cultivating a proprietary plant known as mankai, which is rich in protein, vitamins, and other essential nutrients. Utilizing advanced precision agriculture techniques, Hinoman ensures that its all-natural plant not only meets nutritional needs but does so in an environmentally sustainable manner. The company's innovative approach enables the scalability of its products for local and global markets while minimizing the ecological footprint. Mankai is processed into various consumer offerings, including protein shakes, smoothies, and beverages, allowing customers to enjoy nutrient-dense options that align with contemporary health trends. Hinoman's commitment to safe and sustainable food sources positions it as a key player in the future of nutrition.

GeneDesign, Inc. is an oligonucleotide manufacturer based in Osaka, Japan, established in 2000. The company specializes in the synthesis of DNA, RNA, and LNA oligonucleotides, offering a wide range of production capabilities from micro mole to gram scale. GeneDesign develops and manufactures nucleic acid drugs and provides various research services, allowing clients to access high-quality pharmaceutical products and support for their research needs. As of December 31, 2016, GeneDesign operates as a subsidiary of Ajinomoto Co., Inc.

Orgen Gida Sanayi ve Ticaret is a food company specializing in the production of seasonings and packaged food products. The company focuses on delivering a range of culinary ingredients that enhance flavors in various dishes, catering to the demands of both consumers and businesses in the food industry. Through its commitment to quality and innovation, Orgen aims to provide flavorful solutions that meet diverse culinary needs.

Promasidor, established in 1979 by Robert Rose, is a prominent food and beverage corporation headquartered in Cramerview, South Africa. The company manufactures and distributes a wide array of products across 36 African countries, with primary operations in Nigeria, the Democratic Republic of Congo, Ghana, Algeria, and Angola. Promasidor's product portfolio includes powdered beverages, flavor seasonings, powdered milk, cereals, and other food items, aiming to provide nutritious options for families continent-wide.

Windsor Foods is a prominent manufacturer and marketer of frozen ethnic foods and appetizers, headquartered in Houston, Texas. With a history that spans over 250 years, the company is dedicated to maintaining the highest quality standards in frozen food production. Windsor Foods offers a diverse range of culinary products, including Italian cuisine, Pan-Asian appetizers, Southwestern comfort foods, and Mexican mainstays, positioning itself as a single source for international dishes that are convenient to serve. The company emphasizes a commitment to exceptional customer service, integrity, innovation, and open communication, fostering sustainable growth for its customers, employees, and suppliers.

Ajinomoto Bio-Pharma Services is a contract development and manufacturing organization serving the pharmaceutical and biotechnology industries. It offers integrated preclinical through commercial development and cGMP manufacturing with aseptic fill-finish for small and large molecule APIs and intermediates. The company provides a broad platform portfolio, including Corynex protein expression technology, oligonucleotide synthesis, antibody-drug conjugations, high-potency APIs, biocatalysis, and continuous flow manufacturing. It also conducts gene expression analysis using eXpress Profiling technology and quantitative PCR testing, and performs drug product filling in vials and syringes as well as production of microbial-derived recombinant proteins and plasmid DNA.

Somite.ai is a venture-backed company aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle: It enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders. Incorporated in Oct. 2023, Somite.ai has raised over $10m to date.